Guaiacol

Guaiacol

SCHEMBL28010684

CCNC(=O)O.COc1ccccc1O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.60
CA1 P00915 1/20 0.60
CA2 P00918 1/20 0.60
TSHR P16473 1/20 0.60
MAPT P10636 3/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
IDO1 P14902 1/20 0.46
TDO2 P48775 1/20 0.46
HPGD P15428 2/20 0.45
GLA P06280 1/20 0.45
POLB P06746 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ALDH1A1 P00352 3/20 0.44
HSD17B10 Q99714 2/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Catechol SCHEMBL28023341 0.84 CA1 (0.49) CA1CA2TSHRMAPTKMT2A
Guaiacol SCHEMBL4089861 0.82 CA1 (0.69) TP53CA1CA2TSHRMAPT
Guaiacol SCHEMBL21542 0.82 CA1 (0.82) TP53CA1CA2TSHRMAPT
Guaiacol SCHEMBL5665553 0.80 CA1 (0.78) TP53CA1CA2TSHRMAPT
Guaiacol SCHEMBL27509885 0.80 CA1 (0.86) TP53CA1CA2TSHRMAPT
Guaiacol SCHEMBL28330363 0.80 CA1 (0.86) TP53CA1CA2TSHRMAPT
Guaiacol SCHEMBL11574553 0.80 CA1 (0.95) TP53CA1CA2TSHRMAPT
Guaiacol SCHEMBL27937887 0.80 CA1 (0.95) TP53CA1CA2TSHRMAPT
Guaiacol SCHEMBL3361883 0.79 CA1 (0.69) TP53CA1CA2TSHRMAPT
Guaiacol SCHEMBL27262483 0.79 TP53 (0.69) TP53CA1CA2TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104583196-B The method that 1,4-dibasic pyridazine analog and treatment lack relevant disease to SMN 诺华股份有限公司 2016-10-12 CN disclosed
CN-104583196-A 1,4-disubstituted pyridazine analogs and methods for treating SMN-deficiency-related conditions NOVARTIS AG 2015-04-29 CN disclosed